Overcoming the stromal barrier: technologies to optimize drug delivery in pancreatic cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overcoming the stromal barrier: technologies to optimize drug delivery in pancreatic cancer
Authors
Keywords
-
Journal
Therapeutic Advances in Medical Oncology
Volume 4, Issue 5, Pages 271-279
Publisher
SAGE Publications
Online
2012-05-01
DOI
10.1177/1758834012446008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I trial erlotinib, gemcitabine, and the hedgehog inhibitor, GDC-0449.
- (2017) S. R. Palmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic and Diagnostic Applications of Nanoparticles
- (2012) Mahmoud Youns et al. CURRENT DRUG TARGETS
- Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity
- (2011) Frederico Pittella et al. BIOMATERIALS
- A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone
- (2011) Jeffrey D Altenburg et al. BMC CANCER
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- A Novel Solubility-Enhanced Curcumin Formulation Showing Stability and Maintenance of Anticancer Activity
- (2011) Fang Zhang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Curcumin induces DNA damage and caffeine-insensitive cell cycle arrest in colorectal carcinoma HCT116 cells
- (2011) Jin-Jian Lu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Bioconjugation of Calcium Phosphosilicate Composite Nanoparticles for Selective Targeting of Human Breast and Pancreatic Cancers In Vivo
- (2010) Brian M. Barth et al. ACS Nano
- RNA interference of MBD1 in BxPC-3 human pancreatic cancer cells delivered by PLGA-poloxamer nanoparticles
- (2010) Guopei Luo et al. CANCER BIOLOGY & THERAPY
- Noninvasive Radiofrequency Field Destruction of Pancreatic Adenocarcinoma Xenografts Treated with Targeted Gold Nanoparticles
- (2010) E. S. Glazer et al. CLINICAL CANCER RESEARCH
- Stromal biology and therapy in pancreatic cancer
- (2010) A. Neesse et al. GUT
- Inhibition of NFκB and Pancreatic Cancer Cell and Tumor Growth by Curcumin Is Dependent on Specificity Protein Down-regulation
- (2010) Indira Jutooru et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Half-Antibody Functionalized Lipid−Polymer Hybrid Nanoparticles for Targeted Drug Delivery to Carcinoembryonic Antigen Presenting Pancreatic Cancer Cells
- (2010) Che-Ming Jack Hu et al. MOLECULAR PHARMACEUTICS
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186* signaling pathway
- (2010) Zhang ONCOLOGY REPORTS
- Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis
- (2010) S. Bhattacharyya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
- (2010) K. N. Sugahara et al. SCIENCE
- Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer
- (2010) Francesco Di Costanzo OncoTargets and Therapy
- Polyethyleneimine Coating Enhances the Cellular Uptake of Mesoporous Silica Nanoparticles and Allows Safe Delivery of siRNA and DNA Constructs
- (2009) Tian Xia et al. ACS Nano
- Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application
- (2009) Takahiro Seki et al. CANCER SCIENCE
- A Phase I Study of a 2-Day Lapatinib Chemosensitization Pulse Preceding Nanoparticle Albumin-Bound Paclitaxel for Advanced Solid Malignancies
- (2009) A. J. Chien et al. CLINICAL CANCER RESEARCH
- LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors
- (2009) Guopei Luo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Elevating Blood Pressure as a Strategy to Increase Tumor-targeted Delivery of Macromolecular Drug SMANCS: Cases of Advanced Solid Tumors
- (2009) Akinori Nagamitsu et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- PEG Branched Polymer for Functionalization of Nanomaterials with Ultralong Blood Circulation
- (2009) Giuseppe Prencipe et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
- (2008) C. R. Patra et al. CANCER RESEARCH
- Enhanced distribution of NK012, a polymeric micelle-encapsulated SN-38, and sustained release of SN-38 within tumors can beat a hypovascular tumor
- (2008) Yohei Saito et al. CANCER SCIENCE
- A paracrine requirement for hedgehog signalling in cancer
- (2008) Robert L. Yauch et al. NATURE
- Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
- (2008) E. A. Murphy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started